Clinical application of pharmacokinetic analysis as a biomarker of solitary pulmonary nodules: Dynamic contrast-enhanced MR imaging

Magnetic Resonance in Medicine

Volumn 68, Issue 5, 2012, Pages 1614-1622

  Mamata, Hatsuho ^a   Tokuda, Junichi ^a   Gill, Ritu R ^a   Padera, Robert F ^a   Lenkinski, Robert E ^a   Sugarbaker, David J ^a   Butler, James P ^a   Hatabu, Hiroto ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

biomarker; lung tumor; perfusion MRI; pharmacokinetic parameters

Indexed keywords

BIOMARKERS; CURVE FITTING; IMAGE ENHANCEMENT; IMAGE REGISTRATION; PHARMACOKINETICS; POSITRON EMISSION TOMOGRAPHY; RATE CONSTANTS;

DYNAMIC CONTRAST ENHANCED; LUNG TUMOR; NEGATIVE PREDICTIVE VALUE; NONRIGID IMAGE REGISTRATION; PERFUSION MRI; PHARMACOKINETIC ANALYSIS; PHARMACOKINETIC PARAMETERS; POSITIVE PREDICTIVE VALUES;

MAGNETIC RESONANCE IMAGING;

BIOLOGICAL MARKER; GADOLINIUM DIETHYLENE TRIAMINE PENTAACETIC ACID; RADIOPHARMACEUTICAL AGENT; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EXTRACELLULAR SPACE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LUNG NODULE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; VOXEL BASED MORPHOMETRY;

EID: 84867850613     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24150     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer Statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. SEER Cancer Statistics Review 1975-2006. National Cancer Institute.
3. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr, Doll R,. Mortality from smoking worldwide. Br Med Bull 1996; 52: 12-21.
4. Flehinger BJ, Kimmel M, Melamed MR,. The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest 1992; 101: 1013-1018.
5. Shah R, Sabanathan S, Richardson J, Mearns AJ, Goulden C,. Results of surgical treatment of stage I and II lung cancer. J Cardiovasc Surg (Torino) 1996; 37: 169-172.
6. Ost D, Goldberg J, Rolnitzky L, Rom WN,. Survival after surgery in stage IA and IB non-small cell lung cancer. Am J Respir Crit Care Med 2008; 177: 516-523.
7. Pastorino U,. Lung cancer screening. Br J Cancer 2010; 102: 1681-1686.
8. Kaneko M, Eguchi K, Ohmatsu H, Kakinuma R, Naruke T, Suemasu K, Moriyama N,. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996; 201: 798-802.
9. McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Kuntz KM, Shepard JO, Swensen SJ, Gazelle GS,. Estimating long-term effectiveness of lung cancer screening in the mayo CT screening study. Radiology 2008; 248: 278-287.
10. MacMahon H, Austin JHM, Gamsu G, Herold CJ, Jett JR, Naidich DP, Patz EF, Swensen SJ,. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005; 237: 395-400.
11. Haramati LB, Austin JH,. Complications after CT-guided needle biopsy through aerated versus nonaerated lung. Radiology 1991; 181: 778-783.
12. Gohari A, Haramati LB,. Complications of CT scan-guided lung biopsy: lesion size and depth matter. Chest 2004; 126: 666-668.
13. Scott WJ, Matteotti RS, Egleston BL, Oseni S, Flaherty JF,. A comparison of perioperative outcomes of Video-Assisted Thoracic Surgical (VATS) lobectomy with open thoracotomy and lobectomy: results of an analysis using propensity score based weighting. Ann Surg Innov Res 2010; 4: 1.
14. Midthun DE, Swensen SJ, Jett JR, Hartman TE,. Evaluation of nodules detected by screening for lung cancer with low dose spiral computed tomography. Lung Cancer 2003; 41 (Suppl 2): S40.
15. Davies B, Ghosh S, Hopkinson D, Vaughan R, Rocco G,. Solitary pulmonary nodules: pathological outcome of 150 consecutively resected lesions. Interact Cardiovasc Thorac Surg 2005; 4: 18-20.
16. Zhang M, Kono M,. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology 1997; 205: 471-478.
17. Swensen SJ, Viggiano RW, Midthun DE, Müller NL, Sherrick A, Yamashita K, Naidich DP, Patz EF, Hartman TE, Muhm JR, Weaver AL,. Lung nodule enhancement at CT: multicenter study. Radiology 2000; 214: 73-80.
18. Yi CA, Lee KS, Kim BT, Choi JY, Kwon OJ, Kim H, Shim YM, Chung MJ,. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. J Nucl Med 2006; 47: 443-450.
19. Behzadi A, Ung Y, Lowe V, Deschamps C,. The role of positron emission tomography in the management of non-small cell lung cancer. Can J Surg 2009; 52: 235-242.
20. Kono R, Fujimoto K, Terasaki H, Muller NS, Kato S, Sadohara J, Hayabuchi N, Takamori S,. Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions. Am J Roentgenol 2007; 188: 26-36.
21. Fujimoto K, Abe T, Muller NL, Terasaki H, Kato S, Sadohara J, Kono R, Edamitsu O, Ishitake T, Hayashi A, Rikimaru T, Hayabuchi N,. Small peripheral pulmonary carcinomas evaluated with dynamic MR imaging: correlation with tumor vascularity and prognosis. Radiology 2003; 227: 786-793.
22. Hatabu H, Gaa J, Kim D, Li W, Prasad PV, Edelman RR,. Pulmonary perfusion: qualitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and inversion recovery turbo FLASH. Magn Reson Med 1996; 36: 503-508.
23. Hatabu H, Tadamura E, Levin DL, Chen Q, Li W, Kim D, Prasad PV, Edelman RR,. Quantitative assessment of pulmonary perfusion with dynamic contrast-enhanced MRI. Magn Reson Med 1999; 42: 1033-1038.
24. Schaefer JF, Schneidera V, Vollmara J, Wehrmannb M, Aebertc H, Friedeld G, Vontheine R, Schickf F, Claussena CD,. Solitary pulmonary nodules: association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis. Lung Cancer 2006; 53: 39-49.
25. Ohno Y, Hatabu H, Takenaka D, Adachi S, Kono M, Sugimura K,. Solitary pulmonary nodules: potential role of dynamic MR imaging in management-initial experience. Radiology 2002; 224: 503-511.
26. Zou Y, Zhang M, Wang O, Shang D, Wang L, Yu G,. Quantitative investigation of solitary pulmonary nodules: dynamic contrast-enhanced MRI and histopathologic analysis. Am J Roentgenol 2008; 191: 252-259.
27. Sourbron SP, Buckley DL,. On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med 2011; 66: 735-745.
28. Rueckert D, Sonoda LI, Hayes C, Hill DLG, Leach MO, Hawkes DJ,. Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging 1999; 18: 712-721.
29. Mattes D, Haynor DR, Vesselle H, Lewellen TK, Eubank W,. PET-CT image registration in the chest using free-form deformations. IEEE Trans Med Imaging 2003; 22: 120-128.
30. Gering DT, Nabavi A, Kikinis R, Hata N, O'Donnell LJ, Grimson WE, Jolesz FA, Black PM, Wells WM III,. An integrated visualization system for surgical planning and guidance using image fusion and an open MR. J Magn Reson Imaging 2001; 13: 967-975.
31. Noseworthy MD, Haider MA, Sussman MS, Wright GA,. Free-breathing motion compensation using template matching: a technique allowing for tracer kinetic modeling of liver metastases. J Comput Assist Tomogr 2007; 31: 193-197.
32. Martel AL, Froh MS, Brock KK, Plewes DB, Barber DC,. Evaluating an optical-flow-based registration algorithm for contrast-enhanced magnetic resonance imaging of the breast. Phys Med Biol 2007; 52: 3803-3816.
33. Tokuda J, Mamata H, Gill RR, Patz S, Hata N, Lenkinski RE, Sugarbaker JD, Hatabu H,. Impact of nonrigid motion correction technique on pixel-wise pharmacokinetic analysis of free-breathing pulmonary dynamic contrast-enhanced MR imaging. J Magn Reson Imaging 2011; 33: 968-973.
34. Tofts PS,. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7: 91-101.
35. Mørkenborg J, Pedersen M, Jensen FT, Stødkilde- Jørgensen H, Djurhuus JC, Frøkiaer J,. Quantitative assessment of Gd-DTPA contrast agent from signal enhancement: an in-vitro study. Magn Reson Imaging 2003; 21: 637-643.
36. Nazarpoor M,. Effects of inversion and saturation times on relationships between contrast agent concentrations and signal intensities of T1-weighted magnetic resonance images. Radiol Phys Technol 2010; 3: 120-126.
37. Hlastala MP,. Diffusion capacity heterogeneity. In:, Farhi LE, Tenney SM, editors. Handbook of physiology, Section 3: the respiratory system, Volume IV: gas exchange. American Physiological Society; 1987. pp 217-232.
38. Loring SH, Butler JP,. Gas exchange in body cavities. In:, Farhi LE, Tenney SM, editors. Handbook of physiology, Section 3: the respiratory system, Volume IV: gas exchange. Bethesda, Maryland: American Physiological Society; 1987. pp 283-295.
39. Naish JH, Kershaw LE, Buckley DL, Jackson A, Waterton JC, Parker GJM,. Modeling of contrast agent kinetics in the lung using T1-weighted dynamic contrast-enhanced MRI. Magn Reson Med 2009; 61: 1507-1514.
40. Ng CS, Raunig DL, Jackson EF, Ashton EA, Kelcz F, Kim KB, Kurzrock R, McShane TM,. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses. Am J Roentgenol 2010; 194: W134-W140.
41. Lacerda S, Law M,. Magnetic resonance perfusion and permeability imaging in brain tumors. Neuroimaging Clin N Am 2009; 19: 527-557.
42. Li J, Yu Y, Zhang Y, Bao S, Wu C, Wang X, Li J, Zhang X, Hu J,. A clinically feasible method to estimate pharmacokinetic parameters in breast cancer. Med Phys 2009; 36: 3786-3794.
43. Stefanou D, Batistatou A, Arkoumani E, Ntzani E, Agnantis NJ,. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in small-cell and non-small-cell lung carcinomas. Histol Histopathol 2004; 19: 37-42.
44. Passalidou E, Trivella M, Singh N, Ferguson M, Hu J, Cesario A, Granone P, Nicholson AG, Goldstraw P, Ratcliffe C, Tetlow M, Leigh I, Harris AL, Gatter KC, Pezzella F,. Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. Br J Cancer 2002; 86: 244-249.